Ling Xiao

上海中医药大学

H指数:19

被引数:1,236

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hypoxia-responsive COF nanomedicine co-delivers gambogic acid and BODIPY for synergistic lung cancer PDT suppression

缺氧响应性COF纳米药物共递送 gambogic acid 和 BODIPY 以协同抑制肺癌PDT

Materials & Design

IF7.9

2025-09-050

PREAI

Wake asymmetry of a heated cylinder in a cross flow

横流中加热圆柱体的尾迹不对称性

Experimental Thermal and Fluid Science

IF3.3

2025-07-050

PRE

Changes of food-cue processing in major depressive disorder patients with decreased appetite: An event-related potential study

食欲减退的抑郁症患者食物线索处理的变化：一项事件相关电位研究

APPETITE

IF3.8

2025-06-010

PRE

The antidepressant effect of resveratrol may correlate with the anti-inflammatory pathways mediated by Tas2r123 in hippocampus

白藜芦醇的抗抑郁作用可能与通过Tas2r123介导的海马体抗炎通路相关。

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2025-05-010

PRE

Tas2r123-associated mitochondrial organization and neuroplasticity underlying the antidepressant effect of resveratrol

BRAIN RESEARCH BULLETIN

IF3.7

2025-03-010

The Antidepressant Effect of Resveratrol Is Related to Neuroplasticity Mediated by the ELAVL4-Bdnf mRNA Pathway

白藜芦醇的抗抑郁作用与ELAVL4-Bdnf mRNA通路介导的神经可塑性有关

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IF4.9

2025-01-270

Evaluation of gastrin-releasing peptide receptor, prostate-specific membrane antigen, and neurotensin receptor 1 as potential biomarkers for accurate prostate cancer stratified diagnosis

EJNMMI RESEARCH

IF3

2024-06-161

OAAI

Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease

inflammation research

IF4.1

2024-05-015

Self-Generated Displacement Current of Triboelectric Nanogenerator for Cancer Therapy: Theory and Application (Adv. Mater. Technol. 2/2024)

用于癌症治疗的摩擦纳米发电机的自生位移电流: 理论与应用 (Adv. Mater. Technol. 2/2024)

ADVANCED MATERIALS TECHNOLOGIES

IF6.2

2024-01-220

Stereotactic ablative radiotherapy and FAPα-based cancer vaccine suppresses metastatic tumor growth in 4T1 mouse breast cancer

RADIOTHERAPY AND ONCOLOGY

IF5.3

2023-12-013

OAAI

Widespread Intra- and Inter-Network Dysconnectivity among Large-Scale Resting State Networks in Schizophrenia

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-04-288

OAAI

Preliminary findings on the effect of childhood trauma on the functional connectivity of the anterior cingulate cortex subregions in major depressive disorder

FRONTIERS IN PSYCHIATRY

IF3.2

2023-04-174

OAAI

Prognostic value of sarcopenia in patients with lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors

肌肉减少症在表皮生长因子受体酪氨酸激酶抑制剂或免疫检查点抑制剂治疗肺癌患者中的预后价值

FRONTIERS IN NUTRITION

IF5.1

2023-03-083

OAAI

Polyphyllin VII, a novel moesin inhibitor, suppresses cell growth and overcomes bortezomib resistance in multiple myeloma

CANCER LETTERS

IF10.1

2022-07-0111

PRE

Albendazole inhibits NF-KB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma

CANCER LETTERS

IF10.1

2021-11-0123

PRE

Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy

FUTURE ONCOLOGY

IF2.6

2021-05-199

PRE

Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway

STEM CELL RESEARCH & THERAPY

IF7.3

2019-08-09135

OAAI

The P300 component decreases in a bimodal oddball task in individuals with depression: An event-related potentials study

CLINICAL NEUROPHYSIOLOGY

IF3.6

2018-12-0149

OAAI

Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure

人羊膜上皮干细胞来源的功能性肝细胞样细胞对急性肝衰竭小鼠的治疗作用

STEM CELL RESEARCH & THERAPY

IF7.3

2018-11-2141

OAAI

Leflunomide Increases Hepatic Exposure to Methotrexate and Its Metabolite by Differentially Regulating Multidrug Resistance-Associated Protein Mrp2/3/4 Transporters via Peroxisome Proliferator-Activated Receptor α Activation

MOLECULAR PHARMACOLOGY

IF3

2018-06-0126

OAAI

Ling Xiao

个人简介

教育背景

工作经历

荣誉奖项

研究方向